Internal Medicine
Partner With Us
Advertisement

Oncology & Hematology

thumb description

December 12, 2024

54 Novel Drugs Await FDA Review

An analysis published in the American Journal of Health-System Pharmacy provides an overview of the potential next wave of pharmaceuticals.

Conexiant

thumb description

December 12, 2024

Comparing Ticagrelor and Prasugrel in ACS

In a 17,642-patient cohort study validating ISAR-REACT5's findings, prasugrel showed particular benefit in STEMI patients, with a striking 38% relative risk reduction in adverse events compared to ticagrelor, while maintaining similar bleeding risks.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.